The CCNC embraces a clinical translational science approach towards understanding risk factors and mechanisms involved in clinical presentations across the psychosis-spectrum (e.g., schizophrenia and schizotypal personality disorder) as well as related psychological disorders (e.g., bipolar disorder, autism spectrum disorder, and cannabis use disorder) using both human and animal models. Over the years, the lab has pursued research in understanding the basic neural contributions to psychosis-spectrum and related disorders and has invested in the evaluation of both behavioral and pharmacological treatments of schizophrenia through clinical trials. The lab’s areas of expertise have evolved over the years and have recently expanded to include new foci on affective processes, motor processes, health disparities, and international neuroscience studiesin Africa, which compliment continued interest in perceptual, cognitive, and cerebellar processes.  

For more on current lab studies and the methods used, see our Research page.